2018 Hospital Profile: Massachusetts Eye and Ear Infirmary by Massachusetts. Center for Health Information and Analysis.
2018 Hospital Profile
Overview / Size Payer Mix
Hospital System Affiliation: Public Payer Mix:
Hospital System Surplus (Loss) in FY18: CY17 Commercial Statewide Relative Price:
Change in Ownership (FY14-18): Top 3 Commercial Payers:
Total Staffed Beds:
Change FY17-FY18:
Financial Emergency Department Visits in FY18:
Inpatient NPSR per CMAD: Change FY17-FY18:
Change FY17-FY18: Outpatient Visits in FY18:
`
For descriptions of the metrics, please see the technical appendix.  
% Occupancy:
Special Public Funding: ICB°
Not Applicable
Case Mix Index: 1.37 > statewide (1.14)
Trauma Center Designation:
13.8%
343,5770.5%
9%:91%
$196,980,139
Inpatient:Outpatient Revenue in FY18:
Total Surplus (Loss) in FY18:
Change FY17-FY18:
47.0% Non-HPP Hospital
-8.1%
Utilization
Inpatient Discharges in FY18:
Partners HealthCare System
20,395
0.77
1,187
2.0%$12,384
$826,605,000
MASSACHUSETTS EYE AND EAR INFIRMARY
Boston, MA
Specialty Hospital
Metro Boston
Massachusetts Eye and Ear Infirmary is a small, non-profit specialty hospital located in the Metro Boston region. Mass Eye and Ear provides specialized 
services for disorders of the eye, ear, nose, and throat, including a 24-hour emergency department for these conditions. It provides the region's only 
designated eye trauma center. It serves a patient population ranging in age from newborn to the elderly.  Mass Eye and Ear is a teaching hospital of Harvard 
Medical School. After reporting losses in FY16 and FY17, the hospital reported a $15.9M profit in FY18 and a 9.9% total margin.
Quality
Early Elective Deliveries Rate: 
Change FY14-FY18 (percentage points):
$21,159,302
Total Revenue in FY18: $307,428,383
11.2%Change FY17-FY18:
Outpatient Revenue in FY18:
Not Available
9.3%
2.9
Readmission Rate in FY18:
Blue Cross Blue Shield of Massachusetts
Harvard Pilgrim Health Care
Tufts Associated HMO, Inc.
Joined Partners Effective 4/1/18
41, among the smaller acute hospitals
31.3%
What proportion of adult patient discharges from this hospital resulted in 
a readmission at any hospital within 30 days, and how does this 
compare to the state average?
How many central line-associated blood stream infections (CLABSI), 
catheter-associated urinary tract infections (CAUTI), and surgical site 
infections (SSI) after colon surgery did patients get at this hospital 
compared to what was expected based on the hospital's characteristics 
and case mix?
What were the most common inpatient cases (DRGs) treated at the 
hospital in FY18? What proportion of the region’s cases did this hospital 
treat for each service? 
Where did most of the hospital's inpatients reside? What proportion of 
each community's total discharges was attributed to this hospital?
 - - - Hospital  (1,187) = 0%  of total regional  discharges 
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Data is not available for these measures.
This graph has been suppressed as no single community 
accounted for more than 1% of the hospital's total 
discharges. The hospital reports its patients are primarily 
from Massachusetts, but also across New Englnd, the 
U.S. and in some cases the world.
A58
Key:
Hospital
Cohort: Specialty Hospital Peer Cohort
For descriptions of the metrics, please see the technical appendix.
**FY2018 This is based on audited financial statements which includes only April 1, 2018 through September 30, 2018 when MEEI joined the Partners HealthCare System.
* High Public Payer Hospitals (HPP) receive a minimum of 63% of gross patient service revenue from public payers.
° For more information on Infrastructure and Capacity Building (ICB) special funding, please contact the Massachusetts Executive Office of Health and Human Services (EOHHS).
4.9$       
 Operating Revenue
Non-Operating 
Revenue
5.3$       29.5$     9.2$       11.5$     
What were the hospital's total margin and operating margins between 
FY14 and FY18, and how do these compare to the hospital's peer 
cohort medians?
Revenue, Cost, & Profit/Loss (in millions)
FY 2014 2015 2016 2017
223.4$   227.8$   249.8$   274.2$   149.2$   
Total Profit (Loss) (0.5)$     2.9$       (3.1)$     (1.1)$     
280.1$   
Total Revenue 228.7$   257.3$   259.1$   279.1$   
Total Costs 229.2$   254.3$   262.2$   
160.7$   
144.9$   
15.9$     
2018**
2018 HOSPITAL PROFILE: MASSACHUSETTS EYE AND EAR INFIRMARY
How has the volume of the hospital's inpatient discharges changed 
compared to FY14, and how does this compare to the hospital's peer 
cohort median? (FY14=100)
How has the volume of the hospital's outpatient visits changed 
compared to FY14, and how does this compare to the hospital's peer 
cohort median? (FY14=100)
What was the hospital's net inpatient service revenue per case mix 
adjusted discharge between FY14 and FY18, and how does this 
compare to the hospital's peer cohort median?
How has the hospital's total outpatient revenue changed compared to 
FY14, and how does this compare to the hospital's peer cohort median? 
(FY14=100)
How have the hospital's total revenue and costs changed between FY14 
and FY18?
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